Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

l-Arginine Synthesis from l-Citrulline in Myeloid Cells Drives Host Defense against Mycobacteria In Vivo.

Lange SM, McKell MC, Schmidt SM, Zhao J, Crowther RR, Green LC, Bricker RL, Arnett E, Köhler SE, Schlesinger LS, Setchell KDR, Qualls JE.

J Immunol. 2019 Mar 15;202(6):1747-1754. doi: 10.4049/jimmunol.1801569. Epub 2019 Feb 1.

PMID:
30710047
2.

Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.

Penninx BWJH, Lange SMM.

Dialogues Clin Neurosci. 2018 Mar;20(1):63-73. Review.

3.

l-Citrulline Metabolism in Mice Augments CD4+ T Cell Proliferation and Cytokine Production In Vitro, and Accumulation in the Mycobacteria-Infected Lung.

Lange SM, McKell MC, Schmidt SM, Hossfeld AP, Chaturvedi V, Kinder JM, McAlees JW, Lewkowich IP, Way SS, Turner J, Qualls JE.

Front Immunol. 2017 Nov 16;8:1561. doi: 10.3389/fimmu.2017.01561. eCollection 2017.

4.

A shell regeneration assay to identify biomineralization candidate genes in mytilid mussels.

Hüning AK, Lange SM, Ramesh K, Jacob DE, Jackson DJ, Panknin U, Gutowska MA, Philipp EE, Rosenstiel P, Lucassen M, Melzner F.

Mar Genomics. 2016 Jun;27:57-67. doi: 10.1016/j.margen.2016.03.011. Epub 2016 Apr 12.

PMID:
27083865
5.

The Interaction of CCDC104/BARTL1 with Arl3 and Implications for Ciliary Function.

Lokaj M, Kösling SK, Koerner C, Lange SM, van Beersum SE, van Reeuwijk J, Roepman R, Horn N, Ueffing M, Boldt K, Wittinghofer A.

Structure. 2015 Nov 3;23(11):2122-32. doi: 10.1016/j.str.2015.08.016. Epub 2015 Oct 9.

6.

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer.

Sigmond J, Honeywell RJ, Postma TJ, Dirven CM, de Lange SM, van der Born K, Laan AC, Baayen JC, Van Groeningen CJ, Bergman AM, Giaccone G, Peters GJ.

Ann Oncol. 2009 Jan;20(1):182-7. doi: 10.1093/annonc/mdn543. Epub 2008 Aug 12.

PMID:
18701427
7.

Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population.

Doan QV, Lange SM, Elfant A, Aguilar D, Reyes E, Lynn RB, Dubois RW.

J Med Econ. 2008;11(1):23-40. doi: 10.3111/13696990701815545.

PMID:
19450108
8.

No evidence of gemcitabine accumulation during weekly administration.

de Lange SM, van der Born K, Kroep JR, Jensen HA, Pfeiffer P, Cleverly A, van Groeningen CJ, Peters GJ.

Eur J Clin Pharmacol. 2005 Dec;61(11):843-9. Epub 2005 Nov 10.

PMID:
16283278
9.

A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveforms.

Norton ID, Petersen BT, Bosco J, Nelson DB, Meier PB, Baron TH, Lange SM, Gostout CJ, Loeb DS, Levy MJ, Wiersema MJ, Pochron N.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):1029-33.

PMID:
16234050
10.

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

De Lange SM, van Groeningen CJ, Kroep JR, Van Bochove A, Snijders JF, Peters GJ, Pinedo HM, Giaccone G.

Ann Oncol. 2004 Mar;15(3):484-8.

PMID:
14998853
11.

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

de Lange SM, van Groeningen CJ, Meijer OW, Cuesta MA, Langendijk JA, van Riel JM, Pinedo HM, Peters GJ, Meijer S, Slotman BJ, Giaccone G.

Eur J Cancer. 2002 Jun;38(9):1212-7.

PMID:
12044508
12.

Arterioportal fistula causing acute pancreatitis and hemobilia after liver biopsy.

Machicao VI, Lukens FJ, Lange SM, Scolapio JS.

J Clin Gastroenterol. 2002 Apr;34(4):481-4. Review.

PMID:
11907368
13.

Rational approach to patients with unintentional weight loss.

Bouras EP, Lange SM, Scolapio JS.

Mayo Clin Proc. 2001 Sep;76(9):923-9. Review.

PMID:
11560304
14.

Recurrent severe gastrointestinal bleeding complicating treatment of morbid obesity.

Shahriari A, Hinder RA, Stark ME, Williams HJ, Lange SM.

J Clin Gastroenterol. 2000 Jul;31(1):19-22. No abstract available.

PMID:
10914770
15.

[Team care: a necessity for a child with HIV infection].

Geelen SP, Wolfs TF, Nauta N, de Lange SM, de Graeff-Meeder ER.

Ned Tijdschr Geneeskd. 1999 Aug 14;143(33):1681-5. Dutch.

PMID:
10494306
16.

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.

Angulo P, Dickson ER, Therneau TM, Jorgensen RA, Smith C, DeSotel CK, Lange SM, Anderson ML, Mahoney DW, Lindor KD.

J Hepatol. 1999 May;30(5):830-5.

PMID:
10365809
17.

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.

Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP.

Hepatology. 1995 Oct;22(4 Pt 1):1158-62.

PMID:
7557866
18.

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.

Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, et al.

Gastroenterology. 1994 May;106(5):1284-90.

PMID:
8174890
19.

Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.

Rakela J, Wood JR, Czaja AJ, O'Brien PC, Taswell HF, Bowyer BA, Lange SM, Anderson ML, Parent K.

Mayo Clin Proc. 1990 Oct;65(10):1330-5.

PMID:
2214880
20.

Fulminant hepatitis: Mayo Clinic experience with 34 cases.

Rakela J, Lange SM, Ludwig J, Baldus WP.

Mayo Clin Proc. 1985 May;60(5):289-92.

PMID:
3921780

Supplemental Content

Loading ...
Support Center